Hermann Eye Fund Houston, TX - 77030

Hermann Eye Fund is categorized under Internal Medicine Doctors in Houston, TX and active since 2010.

Hermann Eye Fund was established in 2010, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Sue Mc Raney, Office Manager at the company’s single location by writing to 6400 Fannin St # 1800, Houston, Texas TX 77030 or by phoning (713) 704-1777. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Hermann Eye Fund
Contact Person: Sue Mc Raney, Office Manager
Address: 6400 Fannin St # 1800, Houston, Texas 77030
Phone Number: (713) 704-1777
Website Address: cizikeye.org
Annual Revenue (USD): $10.000.000 to $19.9999.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Hermann Eye Fund was started in 2010 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.

Feel free to contact Sue Mc Raney, Office Manager for inquiries that concern Hermann Eye Fund by calling the company number (713) 704-1777, as your correspondence is most welcome. Additionally, the physical location of the single location of Hermann Eye Fund can be found at the coordinates 29.713592,-95.397886 as well as the street address 6400 Fannin St # 1800 in Houston, Texas 77030.

For its online presence, you may visit Hermann Eye Fund’s website at cizikeye.org and engage with its social media outlets through on Twitter and on Facebook.